← METASTATIC COLORECTAL CANCER MCRC WITH WILD-TYPE RAS: THE CONTINUATION OF ANTI-EGFR THERAPY WITH A CHANGE OF CHEMOTHERAPY AFTER DISEASE PROGRESSION
Download